Company intelligence / Profile preview

Dropworks

Boulder, Colorado, United States

Ownership: Private
Employees: ~2
Development stage: Other

Overview

Dropworks developed FluxPCR™, a digital PCR platform enabling rapid, high-throughput DNA and RNA quantification. This platform allows fully automated molecular assays with digital sensitivity, supporting absolute quantification suitable for applications like cancer genotyping and biomarker discovery. No clinical trial data is applicable as this is a research and diagnostics technology, not a therapeutic.

Modalities: DeviceDiagnostic device
Industry: Molecular Diagnostics

Partnerships

Cuttlesoft (software integration/engineering partner)

Beyond the preview

Go deeper on Dropworks.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dropworks.

Explore the full profile